Climb Bio
CLYM
35 hedge funds and large institutions have $182M invested in Climb Bio in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
9% more funds holding
Funds holding: 32 → 35 (+3)
0.4% more ownership
Funds ownership: 65.08% → 65.48% (+0.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
41% less capital invested
Capital invested by funds: $311M → $182M (-$129M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.59M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$704K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$578K |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$456K |
| 5 |
BlackRock
New York
|
+$363K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$1.37M |
| 2 |
Millennium Management
New York
|
-$1.29M |
| 3 |
D.E. Shaw & Co
New York
|
-$268K |
| 4 |
HF
HRT Financial
New York
|
-$212K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$207K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $40K | – | – | – |
|
|
AIG
27
American International Group
New York
| $39K | -$1.69K | -113 | -3% |
|
28
New York State Common Retirement Fund
Albany,
New York
| $35K | +$50.1K | +3,359 | New |
|
29
Allspring Global Investments
Charlotte,
North Carolina
| $30K | +$42.9K | +2,880 | New |
|
30
Citigroup
New York
| $18K | +$14.2K | +953 | +118% |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $17K | +$12.3K | +823 | +106% |
|
|
SO
32
STRS Ohio
Columbus,
Ohio
| $16K | – | – | – |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| $10K | +$7.6K | +510 | +104% |
|
34
Legal & General Group
London,
United Kingdom
| $7K | – | – | – |
|
|
AIP
35
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | – | – | – |
|
|
36
Millennium Management
New York
| – | -$1.29M | -71,983 | Closed |
|
|
37
D.E. Shaw & Co
New York
| – | -$268K | -14,912 | Closed |
|
|
HF
38
HRT Financial
New York
| – | -$212K | -11,797 | Closed |
|
CLYM Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q4 2021, worth a combined $182M — down 41% from $311M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CLYM positions and 3 closed out — a net gain of 3 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.59M. The largest seller was Tudor Investment Corp, cutting an estimated $1.37M.
- 35 institutional investors held Climb Bio (CLYM) as of Q4 2021, up from 32 in Q3 2021.
- Funds reported $182M of Climb Bio stock for Q4 2021, down 41% quarter-over-quarter.
- 6 funds opened new Climb Bio positions in Q4 2021 and 3 closed out, a net change of +3 holders.
- The largest Climb Bio buyer in Q4 2021 was Vanguard Group, an estimated $1.59M added.
- The largest Climb Bio seller in Q4 2021 was Tudor Investment Corp, an estimated $1.37M sold.
Based on aggregated 13F filings for Q4 2021.